Published in Chromosome Res on January 01, 2004
c-Myc induces chromosomal rearrangements through telomere and chromosome remodeling in the interphase nucleus. Proc Natl Acad Sci U S A (2005) 1.43
New insights into the karyotypic evolution in muroid rodents revealed by multicolor banding applying murine probes. Chromosome Res (2010) 0.95
Duplication of Subcytoband 11E2 of Chromosome 11 Is Regularly Associated with Accelerated Tumor Development in v-abl/myc-Induced Mouse Plasmacytomas. Genes Cancer (2010) 0.84
Generation of multicolor banding probes for chromosomes of different species. Mol Cytogenet (2013) 0.81
Distinct nuclear orientation patterns for mouse chromosome 11 in normal B lymphocytes. BMC Cell Biol (2014) 0.78
Changes in Nuclear Orientation Patterns of Chromosome 11 during Mouse Plasmacytoma Development. Transl Oncol (2015) 0.77
Elongated mouse chromosomes suitable for enhanced molecular cytogenetics. Cytotechnology (2004) 0.75
Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation. Nat Genet (1999) 8.17
A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res (1995) 7.95
A quantitative assay for transformation of bone marrow cells by Abelson murine leukemia virus. J Exp Med (1976) 5.13
Survivin, versatile modulation of cell division and apoptosis in cancer. Oncogene (2003) 4.52
Cytogenetic analysis by chromosome painting using DOP-PCR amplified flow-sorted chromosomes. Genes Chromosomes Cancer (1992) 3.03
Nonrandom chromosome changes involving the Ig gene-carrying chromosomes 12 and 6 in pristane-induced mouse plasmacytomas. Cell (1979) 2.92
The cancer antiapoptosis mouse survivin gene: characterization of locus and transcriptional requirements of basal and cell cycle-dependent expression. Cancer Res (1999) 1.89
Plasmacytomagenesis in mice: model of neoplastic development dependent upon chromosomal translocations. Carcinogenesis (1992) 1.88
The Septin 9 (MSF) gene is amplified and overexpressed in mouse mammary gland adenocarcinomas and human breast cancer cell lines. Cancer Res (2003) 1.56
Chromosomal translocations activating myc sequences and transduction of v-abl are critical events in the rapid induction of plasmacytomas by pristane and abelson virus. J Exp Med (1984) 1.52
High resolution multicolor-banding: a new technique for refined FISH analysis of human chromosomes. Cytogenet Cell Genet (1999) 1.36
Altered expression of the septin gene, SEPT9, in ovarian neoplasia. J Pathol (2003) 1.31
Isolation and mapping of a human septin gene to a region on chromosome 17q, commonly deleted in sporadic epithelial ovarian tumors. Cancer Res (2000) 1.28
Tumor cytogenetics revisited: comparative genomic hybridization and spectral karyotyping. J Mol Med (Berl) (1998) 1.07
Cytogenetic studies on IgA/lambda-producing murine plasmacytomas: regular occurrence of a T(12;15) translocation. Somatic Cell Genet (1980) 1.06
Chromosomal and extrachromosomal instability of the cyclin D2 gene is induced by Myc overexpression. Neoplasia (1999) 0.97
Novel microsatellite markers and single nucleotide polymorphisms refine the tylosis with oesophageal cancer (TOC) minimal region on 17q25 to 42.5 kb: sequencing does not identify the causative gene. Hum Genet (2004) 0.96
Nonrandom chromosomal change (trisomy 11) in murine plasmacytomas induced by an ABL-MYC retrovirus. Cancer Res (1995) 0.89
mBAND: a high resolution multicolor banding technique for the detection of complex intrachromosomal aberrations. Cytogenet Genome Res (2004) 0.87
Alveolar soft part sarcoma--reciprocal translocation between chromosome 17q25 and Xp11. Report of a case with metastases at presentation and review of the literature. Acta Orthop Belg (2003) 0.85
Uncovering novel inter- and intrachromosomal chromosome 1 aberrations in follicular lymphomas by using an innovative multicolor banding technique. Genes Chromosomes Cancer (2002) 0.84
Regions syntenic to human 17q are gained in mouse and rat neuroblastoma. Genes Chromosomes Cancer (2004) 0.82
Improved definition of chromosomal breakpoints using high-resolution multicolour banding. Hum Genet (2001) 0.81
Deregulated expression of c-Myc in a translocation-negative plasmacytoma on extrachromosomal elements that carry IgH and myc genes. Proc Natl Acad Sci U S A (1999) 0.79
Murine plasmacytomas, carrier of the t(12;15) chromosomal translocation, develop from immature/mature B cells not from differentiated plasma cells. Carcinogenesis (1999) 0.76
Elongated mouse chromosomes suitable for enhanced molecular cytogenetics. Cytotechnology (2004) 0.75
Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation (2005) 6.68
Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol (2009) 6.58
Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study. Circulation (2008) 4.43
Prevalence and causes of fatal outcome in catheter ablation of atrial fibrillation. J Am Coll Cardiol (2009) 3.18
Tip60 is a haplo-insufficient tumour suppressor required for an oncogene-induced DNA damage response. Nature (2007) 2.54
Volumetric modulated arc therapy (VMAT) vs. serial tomotherapy, step-and-shoot IMRT and 3D-conformal RT for treatment of prostate cancer. Radiother Oncol (2009) 2.21
Cyclin E amplification/overexpression is a mechanism of trastuzumab resistance in HER2+ breast cancer patients. Proc Natl Acad Sci U S A (2011) 2.18
2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. J Interv Card Electrophysiol (2012) 2.08
Delayed enhancement magnetic resonance imaging predicts response to cardiac resynchronization therapy in patients with intraventricular dyssynchrony. J Am Coll Cardiol (2006) 1.97
Homozygous BUB1B mutation and susceptibility to gastrointestinal neoplasia. N Engl J Med (2010) 1.90
Novel roles for A-type lamins in telomere biology and the DNA damage response pathway. EMBO J (2009) 1.83
Assessment of the cardiac patient for fitness to drive: drive subgroup executive summary. Can J Cardiol (2004) 1.58
Formation of non-random extrachromosomal elements during development, differentiation and oncogenesis. Semin Cancer Biol (2006) 1.52
c-Myc induces chromosomal rearrangements through telomere and chromosome remodeling in the interphase nucleus. Proc Natl Acad Sci U S A (2005) 1.43
RBSP3 (HYA22) is a tumor suppressor gene implicated in major epithelial malignancies. Proc Natl Acad Sci U S A (2004) 1.39
Two different del(5q) clones in a patient with myelodysplastic syndrome. Leuk Lymphoma (2011) 1.39
ATM-Chk2-p53 activation prevents tumorigenesis at an expense of organ homeostasis upon Brca1 deficiency. EMBO J (2006) 1.38
Latent nuclear antigen of Kaposi's sarcoma herpesvirus/human herpesvirus-8 induces and relocates RING3 to nuclear heterochromatin regions. J Gen Virol (2002) 1.34
Functional characterization of the candidate tumor suppressor gene NPRL2/G21 located in 3p21.3C. Cancer Res (2004) 1.29
The three-dimensional organization of telomeres in the nucleus of mammalian cells. BMC Biol (2004) 1.29
Cetuximab-based treatment of metastatic anal cancer: correlation of response with KRAS mutational status. Oncology (2009) 1.27
Utility of cardiovascular magnetic resonance in identifying substrate for malignant ventricular arrhythmias. Circ Cardiovasc Imaging (2011) 1.24
Search for unknown tumor-antagonizing genes. Genes Chromosomes Cancer (2003) 1.22
Intrachromosomal amplification of chromosome 21 (iAMP21) may arise from a breakage-fusion-bridge cycle. Genes Chromosomes Cancer (2007) 1.20
LIM domains-containing protein 1 (LIMD1), a tumor suppressor encoded at chromosome 3p21.3, binds pRB and represses E2F-driven transcription. Proc Natl Acad Sci U S A (2004) 1.20
IMRT for postoperative treatment of gastric cancer: covering large target volumes in the upper abdomen: a comparison of a step-and-shoot and an arc therapy approach. Int J Radiat Oncol Biol Phys (2004) 1.19
Modern criteria to establish human cancer etiology. Cancer Res (2004) 1.18
Segmental duplications and evolutionary plasticity at tumor chromosome break-prone regions. Genome Res (2008) 1.16
Discovery of frequent homozygous deletions in chromosome 3p21.3 LUCA and AP20 regions in renal, lung and breast carcinomas. Oncogene (2004) 1.12
Multicolor-FICTION: expanding the possibilities of combined morphologic, immunophenotypic, and genetic single cell analyses. Am J Pathol (2002) 1.12
NotI subtraction and NotI-specific microarrays to detect copy number and methylation changes in whole genomes. Proc Natl Acad Sci U S A (2002) 1.10
Delayed cardiac tamponade after radiofrequency catheter ablation of atrial fibrillation: a worldwide report. J Am Coll Cardiol (2011) 1.10
IL-21 imposes a type II EBV gene expression on type III and type I B cells by the repression of C- and activation of LMP-1-promoter. Proc Natl Acad Sci U S A (2009) 1.08
Human cell lines engineered for tetracycline-regulated expression of tumor suppressor candidate genes from a frequently affected chromosomal region, 3p21. J Gene Med (2002) 1.08
High-throughput live-cell imaging reveals differential inhibition of tumor cell proliferation by human fibroblasts. Int J Cancer (2010) 1.07
Deletion mapping using quantitative real-time PCR identifies two distinct 3p21.3 regions affected in most cervical carcinomas. Oncogene (2003) 1.06
A deductive mapping strategy for atrial tachycardia following atrial fibrillation ablation: importance of localized reentry. J Cardiovasc Electrophysiol (2008) 1.05
An integrated physical and gene map of the 3.5-Mb chromosome 3p21.3 (AP20) region implicated in major human epithelial malignancies. Cancer Res (2003) 1.04
Genetic and epigenetic analysis of non-small cell lung cancer with NotI-microarrays. Epigenetics (2012) 1.03
A fast radiotherapy paradigm for anal cancer with volumetric modulated arc therapy (VMAT). Radiat Oncol (2009) 1.02
Inactivation of RASSF1C during in vivo tumor growth identifies it as a tumor suppressor gene. Oncogene (2004) 1.01
EBV-encoded EBNA-6 binds and targets MRS18-2 to the nucleus, resulting in the disruption of pRb-E2F1 complexes. Proc Natl Acad Sci U S A (2008) 1.01
EBV-expressing AGS gastric carcinoma cell sublines present increased motility and invasiveness. Int J Cancer (2002) 1.00
Losses of both products of the Cdkn2a/Arf locus contribute to asbestos-induced mesothelioma development and cooperate to accelerate tumorigenesis. PLoS One (2011) 0.99
BCL2 accelerates inflammation-induced BALB/c plasmacytomas and promotes novel tumors with coexisting T(12;15) and T(6;15) translocations. Cancer Res (2003) 0.99
SPR-based immunocapture approach to creating an interfacial sensing architecture: Mapping of the MRS18-2 binding site on retinoblastoma protein. Anal Bioanal Chem (2006) 0.98
Impact of catheter ablation of the coronary sinus on paroxysmal or persistent atrial fibrillation. J Cardiovasc Electrophysiol (2007) 0.97
Microcell-mediated chromosome transfer provides evidence that polysomy promotes structural instability in tumor cell chromosomes through asynchronous replication and breakage within late-replicating regions. Genes Chromosomes Cancer (2004) 0.97
The DNA-based structure of human chromosome 5 in interphase. Am J Hum Genet (2002) 0.97
Profiling three-dimensional nuclear telomeric architecture of myelodysplastic syndromes and acute myeloid leukemia defines patient subgroups. Clin Cancer Res (2012) 0.96
Syncope. Circulation (2013) 0.96
[Guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Executive summary]. Rev Esp Cardiol (2006) 0.96
Optimization of dose distributions for adjuvant locoregional radiotherapy of gastric cancer by IMRT. Strahlenther Onkol (2003) 0.96
Critical tumor-suppressor gene regions on chromosome 3P in major human epithelial malignancies: allelotyping and quantitative real-time PCR. Int J Cancer (2002) 0.96
hUNC93B1: a novel human gene representing a new gene family and encoding an unc-93-like protein. Gene (2002) 0.96
Dynamic chromosomal rearrangements in Hodgkin's lymphoma are due to ongoing three-dimensional nuclear remodeling and breakage-bridge-fusion cycles. Haematologica (2010) 0.96
The transcriptional map of the common eliminated region 1 (C3CER1) in 3p21.3. Eur J Hum Genet (2002) 0.96
MRPS18-2 protein immortalizes primary rat embryonic fibroblasts and endows them with stem cell-like properties. Proc Natl Acad Sci U S A (2009) 0.95
Three-dimensional nuclear telomere architecture is associated with differential time to progression and overall survival in glioblastoma patients. Neoplasia (2010) 0.95
HYAL1 and HYAL2 inhibit tumour growth in vivo but not in vitro. PLoS One (2008) 0.95
Dense-core and diffuse Abeta plaques in TgCRND8 mice studied with synchrotron FTIR microspectroscopy. Biopolymers (2007) 0.95
Control of cyclooxygenase-2 expression and tumorigenesis by endogenous 5-methoxytryptophan. Proc Natl Acad Sci U S A (2012) 0.95
Epigenetics: surveillance team against cancer. Nature (2005) 0.95
c-MYC overexpression in Ba/F3 cells simultaneously elicits genomic instability and apoptosis. Oncogene (2002) 0.95
Epstein-Barr virus immortalization of human B-cells leads to stabilization of hypoxia-induced factor 1 alpha, congruent with the Warburg effect. PLoS One (2012) 0.94
The interferon-alpha responsive gene TMEM7 suppresses cell proliferation and is downregulated in human hepatocellular carcinoma. Cancer Genet Cytogenet (2007) 0.94
Three-dimensional Telomere Signatures of Hodgkin- and Reed-Sternberg Cells at Diagnosis Identify Patients with Poor Response to Conventional Chemotherapy. Transl Oncol (2012) 0.94
Cryoablation: potentials and pitfalls. J Cardiovasc Electrophysiol (2004) 0.94
Nuclear remodeling as a mechanism for genomic instability in cancer. Adv Cancer Res (2011) 0.94
Down regulation of 3p genes, LTF, SLC38A3 and DRR1, upon growth of human chromosome 3-mouse fibrosarcoma hybrids in severe combined immunodeficiency mice. Int J Cancer (2006) 0.93
c-Myc-dependent formation of Robertsonian translocation chromosomes in mouse cells. Neoplasia (2007) 0.93
T cell leukemia I oncogene expression depends on the presence of Epstein-Barr virus in the virus-carrying Burkitt lymphoma lines. Proc Natl Acad Sci U S A (2003) 0.92
The proapoptotic function of SAP provides a clue to the clinical picture of X-linked lymphoproliferative disease. Proc Natl Acad Sci U S A (2009) 0.92
High mutability of the tumor suppressor genes RASSF1 and RBSP3 (CTDSPL) in cancer. PLoS One (2009) 0.91
HHV-8 encoded LANA-1 alters the higher organization of the cell nucleus. Mol Cancer (2007) 0.91
Soluble factors produced by activated CD4+ T cells modulate EBV latency. Proc Natl Acad Sci U S A (2012) 0.90
Centromeres in cell division, evolution, nuclear organization and disease. J Cell Biochem (2008) 0.90
Accuracy of ultrasound-based (BAT) prostate-repositioning: a three-dimensional on-line fiducial-based assessment with cone-beam computed tomography. Int J Radiat Oncol Biol Phys (2008) 0.90
Evaluation of possible prostate displacement induced by pressure applied during transabdominal ultrasound image acquisition. Strahlenther Onkol (2006) 0.90
B-lymphocyte subpopulations are equally susceptible to Epstein-Barr virus infection, irrespective of immunoglobulin isotype expression. Immunology (2003) 0.89
3D imaging of telomeres and nuclear architecture: An emerging tool of 3D nano-morphology-based diagnosis. J Cell Physiol (2011) 0.89
c-MYC-induced genomic instability. Cold Spring Harb Perspect Med (2014) 0.89
Oxaliplatin and capecitabine-based chemoradiotherapy for gastric cancer--an extended phase I MARGIT and AIO trial. Int J Radiat Oncol Biol Phys (2008) 0.89
Development of a novel method for intraoperative radiotherapy during kyphoplasty for spinal metastases (Kypho-IORT). Int J Radiat Oncol Biol Phys (2010) 0.88
The architecture of fibroblast monolayers of different origin differentially influences tumor cell growth. Int J Cancer (2012) 0.88
3D nuclear organization of telomeres in the Hodgkin cell lines U-HO1 and U-HO1-PTPN1: PTPN1 expression prevents the formation of very short telomeres including "t-stumps". BMC Cell Biol (2010) 0.88
In vitro EBV-infected subline of KMH2, derived from Hodgkin lymphoma, expresses only EBNA-1, while CD40 ligand and IL-4 induce LMP-1 but not EBNA-2. Int J Cancer (2005) 0.88
Regulation of transactivation function of the aryl hydrocarbon receptor by the Epstein-Barr virus-encoded EBNA-3 protein. J Biol Chem (2005) 0.88
Burkitt lymphoma. Semin Cancer Biol (2009) 0.88
Loss of HLTF function promotes intestinal carcinogenesis. Mol Cancer (2012) 0.88
3D Telomere FISH defines LMP1-expressing Reed-Sternberg cells as end-stage cells with telomere-poor 'ghost' nuclei and very short telomeres. Lab Invest (2010) 0.88
Telomere-centromere-driven genomic instability contributes to karyotype evolution in a mouse model of melanoma. Neoplasia (2010) 0.88